Lates News

According to AI Express News, Huayuan Securities released a research report on April 26th giving a "buy" rating to Huitai Medical (688617.SH). The reasons for the rating mainly include: 1) Balanced growth in various businesses by 2025, with continuous increase in PFA surgeries; 2) Steady improvement in gross profit margin, optimizing cost structure through lean production. (Daily Economic News)